Escitalopram oxalate是选择性5羟色胺重吸收抑制剂(SSRI),Ki为0.89 nM。
Escitalopram Oxalate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) with Ki of 0.89 nM.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Mnie-Filali O, et al. Encephale, 2007, 33(6), 965-972.
分子式 C22H23FN2O5 |
分子量 414.43 |
CAS号 219861-08-2 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 86 mg/mL |
Water 25 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01814098 | Depressive Disorder, Major | Drug: Escitalopram | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | 2009-07-01 | 2014-05-30 |
NCT01587326 | Depression | Drug: Escitalopram | Beitou Armed Forces Hospital, Taipei, Taiwan | 2012-04-01 | 2012-05-13 | |
NCT02623231 | GBM|Depression | Drug: Escitalopram|Drug: placebo | Tel-Aviv Sourasky Medical Center | Phase 2|Phase 3 | 2015-12-01 | 2015-12-02 |
NCT01594866 | Major Depressive Disorder | Drug: escitalopram|Drug: escitalopram | Seoul National University Hospital|H. Lundbeck A/S | Phase 4 | 2012-05-01 | 2015-12-07 |
NCT01214044 | Depression | Drug: placebo/escitalopram | Oregon Health and Science University|Forest Laboratories | 2008-05-01 | 2010-10-01 | |
NCT00825825 | Antidepressant Activity in Healthy Volunteers | Drug: Escitalopram|Drug: Citalopram|Drug: Placebo | Michael Henry, MD|Forest Laboratories|Steward St. Elizabeth's Medical Center of Boston, Inc. | Phase 4 | 2007-05-01 | 2015-06-16 |
NCT01814085 | Major Depressive Disorder | Drug: Escitalopram | Xian-Janssen Pharmaceutical Ltd. | Phase 4 | 2010-02-01 | 2014-01-02 |
NCT01024140 | Chronic Posttraumatic Stress Disorder | Drug: Escitalopram | Northern California Institute of Research and Education | 2003-02-01 | 2009-12-01 | |
NCT01219686 | Unipolar Depression | Drug: escitalopram, pindolol|Drug: escitalopram|Drug: escitalopram | Markus KOSEL|University Hospital, Geneva|University of Lausanne Hospitals|University Hospital, Basel, Switzerland|H. Lundbeck A/S | Phase 2|Phase 3 | 2010-10-01 | 2015-05-26 |
NCT01149967 | Healthy | Drug: Citalopram Hydrobromide | Dr. Reddy's Laboratories Limited | Phase 1 | 2003-10-01 | 2010-06-23 |
NCT01149980 | Healthy | Drug: Citalopram Hydrobromide | Dr. Reddy's Laboratories Limited | Phase 1 | 2003-10-01 | 2010-06-23 |
NCT02480400 | Major Depressive Disorder | Drug: Escitalopram|Drug: Escitalopram | Abarbanel Mental Health Center|H. Lundbeck A/S | 2010-06-01 | 2015-06-22 | |
NCT01551225 | Irritable Bowel Syndrome|Panic Disorder | Drug: Escitalopram | Maastricht University Medical Center | Phase 4 | 2012-01-01 | 2017-01-11 |
NCT01244724 | Major Depression|Epilepsy | Drug: Lexapro | Weill Medical College of Cornell University|Forest Laboratories | Phase 4 | 2007-10-01 | 2015-07-29 |
NCT00965497 | Major Depression|Multiple Sclerosis|Amyotrophic Lateral Sclerosis | Drug: escitalopram | University of South Carolina | Phase 3 | 2009-07-01 | 2011-08-04 |
NCT00183677 | Depression | Drug: Escitalopram | Massachusetts General Hospital | Phase 4 | 2003-07-01 | 2016-11-04 |
NCT00227292 | Low Back Pain|Depression | Drug: Escitalopram|Drug: Placebo | Martin-Luther-Universitt Halle-Wittenberg | Phase 4 | 2007-11-01 | 2014-06-15 |
NCT01841125 | Alzheimer's Disease | Drug: escitalopram|Drug: Placebo | Konkuk University Medical Center | Phase 4 | 2011-11-01 | 2014-08-12 |
NCT00902226 | Social Anxiety Disorder | Drug: Escitalopram | H. Lundbeck A/S | Phase 4 | 2009-03-01 | 2011-05-11 |
NCT00902564 | Generalized Anxiety Disorder | Drug: Escitalopram | H. Lundbeck A/S | Phase 4 | 2009-03-01 | 2011-05-11 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们